Latest & greatest articles for overdiagnosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on overdiagnosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on overdiagnosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for overdiagnosis

1. Overdiagnosis in primary care: framing the problem and finding solutions. (PubMed)

Overdiagnosis in primary care: framing the problem and finding solutions. Overdiagnosis, is defined as the diagnosis of a condition that, if unrecognized, would not cause symptoms or harm a patient during his or her lifetime, and it is increasingly acknowledged as a consequence of screening for cancer and other conditions. Because preventive care is a crucial component of primary care, which is delivered to the broad population, overdiagnosis in primary care is an important problem from (...) a public health perspective and has far reaching implications. The scope of overdiagnosis as a result of services delivered in primary care is unclear, though overdiagnosis of indolent breast, prostate, thyroid, and lung cancers is well described and overdiagnosis of chronic kidney disease, depression, and attention-deficit/hyperactivity disorder is also recognized. However, overdiagnosis is a known consequence of all screening and can be assumed to occur in many more clinical contexts. Overdiagnosis

2018 BMJ

2. Overdiagnosis

Overdiagnosis Top results for overdiagnosis - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for overdiagnosis The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

3. Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening. (PubMed)

Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening. The toll of inadequate health care is well-substantiated, but recognition is mounting that "too much" is also possible. Overdiagnosis represents one harm of too much medicine, but the concept can be confusing: It is often conflated with related harms (such as overtreatment, misclassification, false-positive results, and overdetection) and is difficult to measure because it cannot be directly observed. Because the U.S (...) . Preventive Services Task Force (USPSTF) issues screening recommendations aimed largely at healthy persons, it has a particular interest in understanding harms related to screening, especially but not limited to overdiagnosis. In support of the USPSTF, the authors summarize the knowledge and provide guidance on defining, estimating, and communicating overdiagnosis in cancer screening. To improve consistency, thinking, and reporting about overdiagnosis, they suggest a specific definition. The authors

2018 Annals of Internal Medicine

4. Overdiagnosis: what it is and what it isn?t

Overdiagnosis: what it is and what it isn?t Overdiagnosis: what it is and what it isn’t | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis: what it is and what it isn’t Article Text Editorial Overdiagnosis: what it is and what it isn’t Free John Brodersen , , Lisa M Schwartz , Carl Heneghan , Jack William O’Sullivan , Jeffrey K Aronson , Steven Woloshin Statistics from Altmetric.com Why then, can one desire too much

2018 Evidence-Based Medicine (Requires free registration)

5. Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’

Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Article Text Letter Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn ’ t ’ Wendy A Rogers 1 , 2 , Yishai Mintzker 3 Statistics from

Full Text available with Trip Pro

2018 Evidence-Based Medicine (Requires free registration)

6. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. (PubMed)

Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. Objective To analyse stage specific incidence of breast cancer in the Netherlands where women have been invited to biennial mammography screening since 1989 (ages 50-69) and 1997 (ages 70-75), and to assess changes in breast cancer mortality and quantified overdiagnosis.Design Population based study.Setting Mammography screening programme, the Netherlands.Participants Dutch women of all (...) ages, 1989 to 2012.Main outcome measures Stage specific age adjusted incidence of breast cancer from 1989 to 2012. The extra numbers of in situ and stage 1 breast tumours associated with screening were estimated by comparing rates in women aged 50-74 with those in age groups not invited to screening. Overdiagnosis was estimated after subtraction of the lead time cancers. Breast cancer mortality reductions and overdiagnosis during 2010-12 were computed without (scenario 1) and with (scenario 2

Full Text available with Trip Pro

2017 BMJ

7. Rising Thyroid Cancer Incidence in Southern India: An Epidemic of Overdiagnosis? (PubMed)

Rising Thyroid Cancer Incidence in Southern India: An Epidemic of Overdiagnosis? Thyroid cancer incidence is rising in high-income countries. This increase in disease burden is attributed to the phenomenon of overdiagnosis.We aimed to investigate trends in thyroid cancer rates in India, focusing on the state of Kerala in southern India, which has reported a high incidence of the disease.Population-based study using data from the National Cancer Registry Program.We used data from the Population (...) to overdiagnosis.

Full Text available with Trip Pro

2017 Journal of the Endocrine Society

8. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. (PubMed)

Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis. Effective breast cancer screening should detect early-stage cancer and prevent advanced disease.To assess the association between screening and the size of detected tumors and to estimate overdiagnosis (detection of tumors that would not become clinically relevant).Cohort study.Denmark from 1980 to 2010.Women aged 35 to 84 years.Screening programs offering biennial mammography for women aged 50 to 69 years (...) beginning in different regions at different times.Trends in the incidence of advanced (>20 mm) and nonadvanced (≤20 mm) breast cancer tumors in screened and nonscreened women were measured. Two approaches were used to estimate the amount of overdiagnosis: comparing the incidence of advanced and nonadvanced tumors among women aged 50 to 84 years in screening and nonscreening areas; and comparing the incidence for nonadvanced tumors among women aged 35 to 49, 50 to 69, and 70 to 84 years in screening

2017 Annals of Internal Medicine

9. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. (PubMed)

Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. The goal of screening mammography is to detect small malignant tumors before they grow large enough to cause symptoms. Effective screening should therefore lead to the detection of a greater number of small tumors, followed by fewer large tumors over time.We used data from the Surveillance, Epidemiology, and End Results (SEER) program, 1975 through 2012, to calculate the tumor-size distribution and size-specific

Full Text available with Trip Pro

2016 NEJM

10. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. (PubMed)

Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. 27532827 2016 08 23 2016 08 18 1533-4406 375 7 2016 Aug 18 The New England journal of medicine N. Engl. J. Med. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. 614-7 10.1056/NEJMp1604412 Vaccarella Salvatore S From the International Agency for Research on Cancer, Lyon, France (S.V., S.F., F.B., C.P.W., M.P.); and the Cancer Epidemiology Unit, CRO (Centro di Riferimento Oncologico) Aviano

2016 NEJM

11. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. (PubMed)

Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. To determine the optimal method for quantifying and monitoring overdiagnosis in cancer screening over time.Systematic review of primary research studies of any design that quantified overdiagnosis from screening for nine types of cancer. We used explicit criteria to critically appraise individual studies and assess strength of the body of evidence for each study design (double blinded review (...) ), and assessed the potential for each study design to accurately quantify and monitor overdiagnosis over time.PubMed and Embase up to 28 February 2014; hand searching of systematic reviews.English language studies of any design that quantified overdiagnosis for any of nine common cancers (prostate, breast, lung, colorectal, melanoma, bladder, renal, thyroid, and uterine); excluded case series, case reports, and reviews that only reported results of other studies.52 studies met the inclusion criteria. We

Full Text available with Trip Pro

2015 BMJ

12. Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis

Observational study: US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Article Text Therapeutics/Prevention Observational study US counties with higher rates of breast cancer screening have higher rates of incidence with no concomitant decrease in breast cancer mortality suggesting overdiagnosis Rebecca A Hubbard Statistics from Altmetric.com Commentary on: Harding C , Pompei F , Burmistrov D , et al . Breast Cancer Screening, Incidence

2015 Evidence-Based Medicine (Requires free registration)

13. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 Cancer Australia

14. Overdiagnosis from mammographic screening

Overdiagnosis from mammographic screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 MHRA Drug Safety Update

15. Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk

Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your (...) browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis in breast cancer screening: women have

2014 Evidence-Based Nursing

16. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. (PubMed)

Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Knowledge of the likelihood that a screening-detected case of cancer has been overdiagnosed is vitally important to make treatment decisions and develop screening policy. An overdiagnosed case is an excess case detected by screening. Estimates of the frequency of overdiagnosis in breast and prostate cancer screening vary greatly across studies. This article identifies features (...) of overdiagnosis studies that influence results and shows their effect by using published research. First, different ways to define and measure overdiagnosis are considered. Second, contextual features and how they affect overdiagnosis estimates are examined. Third, the effect of estimation approach is discussed. Many studies use excess incidence under screening as a proxy for overdiagnosis. Others use statistical models to make inferences about lead time or natural history and then derive the corresponding

Full Text available with Trip Pro

2013 Annals of Internal Medicine

17. Overdiagnosis in screening mammography in Denmark: population based cohort study. (PubMed)

Overdiagnosis in screening mammography in Denmark: population based cohort study. To use data from two longstanding, population based screening programmes to study overdiagnosis in screening mammography.Population based cohort study.Copenhagen municipality (from 1991) and Funen County (from 1993), Denmark.57,763 women targeted by organised screening, aged 56-69 when the screening programmes started, and followed up to 2009.Overdiagnosis of breast cancer in women targeted by screening, assessed (...) for Copenhagen and 1.02 for Funen; for participants followed for at least eight years after the end of screening, they were 1.05 and 1.01. A pooled estimate gave 1.040 (0.99 to 1.09) for all targeted women and 1.023 (0.97 to 1.08) for targeted women followed for at least eight years after the end of screening.On the basis of combined data from the two screening programmes, this study indicated that overdiagnosis most likely amounted to 2.3% (95% confidence interval -3% to 8%) in targeted women. Among

Full Text available with Trip Pro

2013 BMJ

18. Women's views on overdiagnosis in breast cancer screening: a qualitative study. (PubMed)

Women's views on overdiagnosis in breast cancer screening: a qualitative study. To elicit women's responses to information about the nature and extent of overdiagnosis in mammography screening (detecting disease that would not present clinically during the woman's lifetime) and explore how awareness of overdiagnosis might influence attitudes and intentions about screening.Qualitative study using focus groups that included a presentation explaining overdiagnosis, incorporating different (...) published estimates of its rate (1-10%, 30%, 50%) and information on the mortality benefit of screening, with guided group discussionsSydney, AustraliaFifty women aged 40-79 years with no personal history of breast cancer and with varying levels of education and participation in screening.Prior awareness of breast cancer overdiagnosis was minimal. Women generally reacted with surprise, but most came to understand the issue. Responses to overdiagnosis and the different estimates of its magnitude were

Full Text available with Trip Pro

2013 BMJ

19. Observational study: Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers

Observational study: Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers Article Text Online articles Observational

2013 Evidence-Based Medicine (Requires free registration)

20. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. (PubMed)

Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Lung cancer screening may detect cancer that will never become symptomatic (overdiagnosis), leading to overtreatment. Changes in size on sequential low-dose computed tomography (LDCT) screening, expressed as volume-doubling time (VDT), may help to distinguish aggressive cancer from cases that are unlikely to become symptomatic.To assess VDT for screening-detected lung cancer as an indicator (...) were stage I, for which survival was good.This is a retrospective study. Volume-doubling time can only indicate overdiagnosis and was estimated for new cancer from 1 measurement (a diameter of 2 mm assumed the previous year).Slow-growing or indolent cancer comprised approximately 25% of incident cases, many of which may have been overdiagnosed. To limit overtreatment in these cases, minimally invasive limited resection and nonsurgical treatments should be investigated.Italian Association for Cancer

2012 Annals of Internal Medicine